Nyse american to suspend trading immediately in ampio pharmaceuticals, inc. (ampe) and commence delisting proceedings

New york--(business wire)--nyse american llc (“nyse american” or the “exchange”) announced today that the staff of nyse regulation has determined to commence proceedings to delist the common stock of ampio pharmaceuticals, inc. (the “company”) — ticker symbol ampe — from the exchange. trading in the company's common stock on the nyse american will be suspended immediately. nyse regulation has determined that the company is no longer suitable for listing pursuant to section 1003(f)(v) of the nys
AMPE Ratings Summary
AMPE Quant Ranking